Morphine protects against intracellular amyloid toxicity by inducing estradiol release and upregulation of Hsp70

Journal of Neuroscience

Volumn 31, Issue 45, 2011, Pages 16227-16240

  Cui, Jia ^a   Wang, Yunfeng ^a   Dong, Qiping ^a   Wu, Shimin ^a   Xiao, Xianzhong ^b   Hu, Jianying ^a   Chai, Zhen ^a   Zhang, Yan ^a  

^a PEKING UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AROMATASE; ENDOMORPHIN 1; ENDOMORPHIN 2; ESTRADIOL; HEAT SHOCK PROTEIN 70; MORPHINE; PROTEASOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ELECTRIC CAPACITANCE; ENZYME ACTIVITY; ESTROGEN RELEASE; FETUS; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MAZE TEST; MENTAL PERFORMANCE; MOUSE; NERVE CELL CULTURE; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; UPREGULATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; BRAIN; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTRADIOL; FETUS; GREEN FLUORESCENT PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IN SITU NICK-END LABELING; MALE; MAZE LEARNING; MEMBRANE POTENTIALS; MICE; MICE, TRANSGENIC; MICROINJECTIONS; MORPHINE; NARCOTICS; NEURONS; OLIGOPEPTIDES; PATCH-CLAMP TECHNIQUES; PEPTIDE FRAGMENTS; PRESENILIN-1; RATS; RATS, SPRAGUE-DAWLEY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRANSFECTION; UP-REGULATION;

EID: 80755168028     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3915-11.2011     Document Type: Article

References (52)

1. Ammon-Treiber S, Grecksch G, Stumm R, Riechert U, Tischmeyer H, Reichenauer A, Hollt V (2004) Rapid, transient, and dose-dependent expression of hsp70 messenger RNA in the rat brain after morphine treatment. Cell Stress Chaperones 9:182-197.
2. Ammon-Treiber S, Stolze D, Schroder H, Loh H, Hollt V (2005) Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model. Neuropharmacology 49: 1160-1169.
3. Avdoshina V, Biggio F, Palchik G, Campbell LA, Mocchetti I (2010) Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120. Glia 58:1630-1639.
4. Baldereschi M, Di Carlo A, Lepore V, Bracco L, Maggi S, Grigoletto F, Scarlato G, Amaducci L (1998) Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 50:996-1002.
5. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad SciU S A83:2496-2500.
6. Birge SJ (1996) Is there a role for estrogen replacement therapy in the prevention and treatment of dementia? J Am Geriatr Soc 44:865-870.
7. Blanchard V, Moussaoui S, Czech C, Touchet N, Bonici B, Planche M, Canton T, Jedidi I, Gohin M, Wirths O, Bayer TA, Langui D, Duyckaerts C, Tremp G, Pradier L (2003) Time sequence of maturation of dystrophic neuritis associated with Abeta deposits in APP/PS1 transgenic mice. Exp Neurol 184:247-263.
8. Charron C, Messier C, Plamondon H (2008) Neuroprotection and functional recovery conferred by administration of kappa- and delta 1-opioid agonists in a rat model of global ischemia. Physiol Behav 93:502-511.
9. Cui J, Chen Q, Yu LC, Zhang Y (2008) Chronic morphine application is protective against cell death in primary human neurons. Neuroreport 19:1745-1749.
10. Day RN, Walder JA, Maurer RA (1989) A protein kinase inhibitor gene reduces both basal and multihormone-stimulated prolactin gene transcription. J Biol Chem 264:431-436.
11. Duman RS, Tallman JF, Nestler EJ (1988) Acute and chronic opiateregulation of adenylate cyclase in brain: specific effects in locus coeruleus. J Pharmacol Exp Ther 246:1033-1039.
12. Fanjun M, Junfa L, Bingxi Z, Fang J (2006) Npkcepsilon andNMDAreceptors participate in neuroprotection induced by morphine pretreatment. J Neurosurg Anesthesiol 18:119-124.
13. Farooqui M, Geng ZH, Stephenson EJ, Zaveri N, Yee D, Gupta K (2006) Naloxone acts as an antagonist of estrogen receptor activity in MCF-7 cells. Mol Cancer Ther 5:611-620.
14. Galen Buckwalter J, Crooks VC, Robins SB, Petitti DB (2004) Hormone use and cognitive performance in women of advanced age. J Am Geriatr Soc 52:182-186.
15. Good TA, Murphy RM (1996) Effect of beta-amyloid block of the fastinactivating Kchannel on intracellular Ca2and excitability in a modeled neuron. Proc Natl Acad Sci U S A 93:15130-15135.
16. Hou JF, Cui J, Yu LC, Zhang Y (2009) Intracellular amyloid induces impairments on electrophysiological properties of cultured human neurons. Neurosci Lett 462:294-299.
17. Kang DH, Yu ES, Yoon KI, Johnson R (2004) The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. AmJ Pathol 164:679-688.
18. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521.
19. Kim HS, Park CH, Cha SH, Lee JH, Lee S, Kim Y, Rah JC, Jeong SJ, Suh YH (2000) Carboxyl-terminal fragment of Alzheimer's APP destabilizes calcium homeostasis and renders neuronal cells vulnerable to excitotoxicity. Faseb J 14:1508-1517.
20. Kim MS, Cheong YP, So HS, Lee KM, Kim TY, Oh J, Chung YT, Son Y, Kim BR, Park R (2001) Protective effects of morphine in peroxynitriteinduced apoptosis of primary rat neonatal astrocytes: potential involvement of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem Pharmacol 61:779-786.
21. Klepstad P, Skogvoll E, Kaasa S, Borchgrevink PC (2000) Circadian distribution of oral opioid consumption in cancer patients. Methods Find Exp Clin Pharmacol 22:753-755.
22. Kretz O, Fester L, Wehrenberg U, Zhou L, Brauckmann S, Zhao S, Prange-Kiel J, Naumann T, Jarry H, Frotscher M, Rune GM (2004) Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci 24:5913-5921.
23. LeBlanc A (1995) Increased production of 4 kDa amyloid beta peptide in serum deprived human primary neuron cultures: possible involvement of apoptosis. J Neurosci 15:7837-7846.
24. LeBlanc A (2002) Estrogen and Alzheimer's disease. Curr Opin Investig Drugs 3:768-773.
25. Lephart ED (1996) Areview of brain aromatase cytochrome P450. Brain Res Brain Res Rev 22:1-26.
26. Li M, Chen L, Lee DH, Yu LC, Zhang Y (2007) The role of intracellular amyloid beta in Alzheimer's disease. Prog Neurobiol 83:131-139.
27. Liu H, McPherson BC, Yao Z (2001) Preconditioning attenuates apoptosis and necrosis: role of protein kinase C epsilon and -delta isoforms. Am J Physiol Heart Circ Physiol 281:H404-410.
28. Liu Y, Nie YM, Wu WK (2008) The effect of PKC activation and Smac release on inhibition of myocardial cell apoptosis by Sini Decoction. Zhong Yao Cai 31:1675-1678.
29. Maki PM, Resnick SM (2001) Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 14:789-801.
30. McMillan DR, Xiao X, Shao L, Graves K, Benjamin IJ (1998) Targeted disruption of heat shock transcription factor 1 abolishes thermotolerance and protection against heat-inducible apoptosis. J Biol Chem 273:7523-7528.
31. Mulnard RA (2000) Estrogen as a treatment for Alzheimer disease. JAMA 284:307-308.
32. Ohyagi Y (2008) Intracellular amyloid beta-protein as a therapeutic target for treating Alzheimer's disease. Curr Alzheimer Res 5:555-561.
33. Pak T, Cadet P, Mantione KJ, Stefano GB (2005) Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protective mechanism for Alzheimer's disease. Med Sci Monit 11:BR357-BR366.
34. Pinkerton JV, Henderson VW (2005) Estrogen and cognition, with a focus on Alzheimer's disease. Semin Reprod Med 23:172-179.
35. Prange-Kiel J, Fester L, Zhou L, Lauke H, Carretero J, Rune GM (2006) Inhibition of hippocampal estrogen synthesis causes region-specific downregulation of synaptic protein expression in hippocampal neurons. Hippocampus 16:464-471.
36. Prange-Kiel J, Jarry H, Schoen M, Kohlmann P, Lohse C, Zhou L, Rune GM (2008) Gonadotropin-releasing hormone regulates spine density via its regulatory role in hippocampal estrogen synthesis. J Cell Biol 180:417-426.
37. Price DL, Sisodia SS (1998) Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21:479-505.
38. Qian L, Tan KS, Wei SJ, Wu HM, Xu Z, Wilson B, Lu RB, Hong JS, Flood PM (2007) Microglia-mediated neurotoxicity is inhibited by morphine through an opioid receptor-independent reduction of NADPH oxidase activity. J Immunol 179:1198-1209.
39. Rambhia S, Mantione KJ, Stefano GB, Cadet P (2005) Morphine modulation of the ubiquitin-proteasome complex is neuroprotective. Med Sci Monit 11:BR386-BR396.
40. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D (2003) Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2663-2672.
41. Sanchez-Simon FM, Arenzana FJ, Rodriguez RE (2010) In vivo effects of morphine on neuronal fate and opioid receptor expression in zebrafish embryos. Eur J Neurosci 32:550-559.
42. Schneider LS, Finch CE (1997) Can estrogens prevent neurodegeneration? Drugs Aging 11:87-95.
43. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN, 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289:2651-2662.
44. Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O (2004) Progressive age-related development of Alzheimer-like pathology in APP/ PS1 mice. Ann Neurol 55:801-814.
45. Wagner EJ, Ronnekleiv OK, Kelly MJ (1998) Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling. J Pharmacol Exp Ther 285:1266-1273.
46. Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279:688-695.
47. Zhang Y, McLaughlin R, Goodyer C, Le Blanc A (2002) Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons. J Cell Biol 156:519-529.
48. Zhang Y, Champagne N, Beitel LK, Goodyer CG, Trifiro M, LeBlanc A (2004) Estrogen and androgen protection of human neurons against intracellular amyloid beta1-42 toxicity through heat shock protein 70. J Neurosci 24:5315-5321.
49. Zhang Y, Chen Q, Yu LC (2008) Morphine: a protective or destructive role in neurons? Neuroscientist 14:561-570.
50. Zhao P, Huang Y, Zuo Z (2006) Opioid preconditioning induces opioid receptor-dependent delayed neuroprotection against ischemia in rats. J Neuropathol Exp Neurol 65:945-952.
51. Zhou Q, Krebs JF, Snipas SJ, Price A, Alnemri ES, Tomaselli KJ, Salvesen GS (1998) Interaction of the baculovirus anti-apoptotic protein p35 with caspase-specificity, kinetics, and characterization of the caspase/p35 complex. Biochemistry 37:10757-10765.
52. Zwain IH, Yen SS (1999) Neurosteroidogenesis in astrocytes, oligodendrocytes, and neurons of cerebral cortex of rat brain. Endocrinology 140: 3843-3852.